Glycogen synthase kinase-3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy study

Synapse

Volumn 67, Issue 6, 2013, Pages 313-327

  Gandy, Johanna C ^a   Melendez Ferro, Miguel ^b   Bijur, Gautam N ^b   Van Leuven, Fred ^c   Roche, Joy K ^b   Lechat, Benoit ^c   Devijver, Herman ^c   Demedts, David ^c   Perez Costas, Emma ^b   Roberts, Rosalinda C ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Amygdala; Hippocampus; Immunohistochemistry; Limbic system; Neurodegenerative disorders; Neuropathology

Indexed keywords

AMYLOID PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

AGE; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CELL DENSITY; CELL LABELING; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; ENZYME LOCALIZATION; FEMALE; MALE; MICROSCOPY; MICROTUBULE; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RIBOSOME; ROUGH ENDOPLASMIC RETICULUM; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DENDRITES; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, TRANSGENIC; MICROTUBULES; NEUROFIBRILLARY TANGLES; RIBOSOMES; TAU PROTEINS;

EID: 84876440904     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21642     Document Type: Article

References (53)

1. Balleza-Tapia H, Pena F. 2009. Pharmacology of the intracellular pathways activated by amyloid beta protein. Mini Rev Med Chem 9:724-740.
2. Chong S-A, Benilova I, Shaban H, De Strooper B, Devijver H, Moechars D, Eberle W, Bartic C, Van Leuven F, Callewaert G. 2011. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: A multi-electrode array study. Neurobiol Dis 44:284-291.
3. Dewachter I, Ris L, Jaworski T, Seymour CM, Kremer A, Borghgraef P, De Vijver H, Godaux E, Van Leuven F. 2009. GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9. Neurobiol Dis 35:193-200.
4. Ermak G, Harris CD, Battocchio D, Davies KJA. 2006. RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta. FEBS J 273:2100-2109.
5. Glenner GG, Wong CW. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
6. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. 1986. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084-6089.
7. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147:58-62.
8. Harris CD, Ermak G, Davies KJA. 2007. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients. FEBS Journal 274:1715-1724.
9. Hernandez F, Gomez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J. 2010. GSK3: A possible link between beta amyloid peptide and tau protein. Exp Neurol 223:322-325.
10. Herzog AG, Kemper TL. 1980. Amygdaloid changes in aging and dementia. Arch Neurol 37:625-629.
11. Hooper C, Markevich V, Plattner F, Killick R, Schofield E, Engel T, Hernandez F, Anderton B, Rosenblum K, Bliss T, Cooke SF, Avila J, Lucas JJ, Giese KP, Stephenson J, Lovestone S. 2007. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur J Neurosci 25:81-86.
12. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R. 2006. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843.
13. Ihara Y, Nukina N, Miura R, Ogawara M. 1986. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J Biochem 99:1807-1810.
14. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. 2005. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198-210.
15. Ishiguro K, Omori A, Takamatsu M, Sato K, Arioka M, Uchida T, Imahori K. 1992. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci Lett 148:202-206.
16. Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH. 2003. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 163:1057-1067.
17. Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo S-C, Bru-Mercier G, Dickinson B, Scullion S, Sheng M, Collingridge G, Cho K. 2011. Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat Neurosci 14:545-547.
18. Lee SJ, Chung YH, Joo KM, Lim HC, Jeon GS, Kim D, Lee WB, Kim YS, Cha CI. 2006. Age-related changes in glycogen synthase kinase 3beta (GSK3beta) immunoreactivity in the central nervous system of rats. Neurosci Lett 409:134-139.
19. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP. 2002. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol 103:91-99.
20. Leroy K, Brion JP. 1999. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279-293.
21. Leroy K, Yilmaz Z, Brion JP. 2007. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33:43-55.
22. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. 2009. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788-801.
23. Lindwall G, Cole RD. 1984. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259:5301-5305.
24. Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallardo FV, Davies KJ, Vina J. 2011. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. J Alzheimers Dis 27:701-709.
25. Lovestone S, Davis DR, Webster MT, Kaech S, Brion JP, Matus A, Anderton BH. 1999. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol Psychiatry 45:995-1003.
26. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
27. Meares GP, Mines MA, Beurel E, Eom TY, Song L, Zmijewska AA, Jope RS. 2011. Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells. Exp Cell Res 317:1621-1628.
28. Meraz-Rios MA, Lira-De Leon KI, Campos-Pena V, De Anda-Hernandez MA, Mena-Lopez R. 2010. Tau oligomers and aggregation in Alzheimer's disease. J Neurochem 112:1353-1367.
29. Mines MA, Beurel E, Jope RS. 2011. Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3. Int J Alzheimers Dis 2011:861072.
30. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. 1999. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483-6492.
31. Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B. 2000. Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol 57:885-887.
32. Muyllaert D, Kremer A, Jaworski T, Borghgraef P, Devijver H, Croes S, Dewachter I, Van Leuven F. 2008. Glycogen synthase kinase-β, or a link between amyloid and tau pathology? Genes Brain Behav 7:57-66.
33. Pandey GN, Dwivedi Y, Rizavi HS, Teppen T, Gaszner GL, Roberts RC, Conley RR. 2009. GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide. Neurochem Res 34:274-285.
34. Pap M, Cooper GM. 2002. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway. Mol Cell Biol 22:578-586.
35. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. 1999. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58:1010-1019.
36. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I. 1997. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78.
37. Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL. 2008. The role of GSK-3 in synaptic plasticity. Br J Pharmacol 153 Suppl 1:S428-437.
38. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL. 2007. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703-717.
39. Perez-Costas E, Gandy JC, Melendez-Ferro M, Roberts RC, Bijur GN. 2010. Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain. PLoS One 5:e8911.
40. Puzzo D, Privitera L, Fa M, Staniszewski A, Hashimoto G, Aziz F, Sakurai M, Ribe EM, Troy CM, Mercken M, Jung SS, Palmeri A, Arancio O. 2011. Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69:819-830.
41. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. 2008. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842.
42. Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheelock TR, Yanagawa H, Imahori K, Nixon RA. 1996. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res 737:119-132.
43. Song L, De Sarno P, Jope RS. 2002. Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem 277:44701-44708.
44. Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F. 2000. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 275:41340-41349.
45. Takahashi M, Tomizawa K, Ishiguro K. 2000. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res 857:193-206.
46. Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, Imahori K. 1994. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem 63:245-255.
47. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F. 2008. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172:786-798.
48. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539.
49. Welsh GI, Proud CG. 1993. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294:625-629.
50. Woodgett JR. 1990. Molecular cloning and expression of glycogen synthase kinase-3/factor A. Embo J 9:2431-2438.
51. Xu M, Shibayama H, Kobayashi H, Yamada K, Ishihara R, Zhao P, Takeuchi T, Yoshida K, Inagaki T, Nokura K. 1992. Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients-a quantitative study. Acta Neuropathol 85:1-9.
52. Zhang YW, Thompson R, Zhang H, Xu H. 2011. APP processing in Alzheimer's disease. Mol Brain 4:3.
53. Zhou FQ, Snider WD. 2005. Cell biology. GSK-3beta and microtubule assembly in axons. Science 308:211-214.